Tiny tubes battle for glaucoma relief: which implant wins?
NCT ID NCT07359547
Summary
This study compares two small, implantable devices designed to lower eye pressure in adults with open-angle glaucoma. Participants will receive either the XEN-63 Gel Stent or PRESERFLO MicroShunt during a single surgery, then be followed for two years. Researchers want to see which device works better at reducing eye pressure and the need for daily eye-drop medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA 1, OPEN ANGLE, D (DISORDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ULS Santa Maria
NOT_YET_RECRUITINGLisbon, Lisbon District, 1649-028, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospitals UZ Leuven
RECRUITINGLeuven, Vlaams-brabant, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Bonn
RECRUITINGBonn, North Rhine-Westphalia, D-53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.